Role of AT1 receptors and autonomic nervous system in mediating acute pressor responses to ANG II in anesthetized mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 277, Issue 5 40-5, 1999, Pages

  Bivalacqua, Trinity J ^a   Dalal, Ajay ^a   Champion, Hunter C ^a   Kadowitz, Philip J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; AT2 receptors; Cardiac output; Heart rate; Mouse; Systemic arterial pressure

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATROPINE; CANDESARTAN; ENALAPRILAT; HEXAMETHONIUM; PHENTOLAMINE; PROPRANOLOL;

ANIMAL EXPERIMENT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL;

EID: 0032714118     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1999.277.5.e838     Document Type: Article

References (33)

1. Bauer, P. H., A. T. Chiu, and J. C. Garrison. Dup 753 can antagonize the effects of angiotensin II in rat liver. Mol. Pharmacol. 39: 579-585, 1991.
2. 2 subtype. J. Med. Chem. 34: 3248-3260, 1991.
3. 1 receptors. Hypertension 30: 1060-1066, 1997.
4. 1 receptors in the rat. Am. J. Physiol. 274 (Endocrinol. Metab. 37): E115-E123, 1998.
5. Chang, R. S. L., and V. J. Lotti. Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands. Mol. Pharmacol. 37: 347-352, 1990.
6. 2 receptor. J. Hum. Hypertens. 12: 311-318, 1998.
7. Dudley, D. T., R. L. Panek, T. C. Major, G. H. Lu, R. F. Burns, B. A. Klinkefus, J. C. Hodges, and R. E. Weishaar. Subclasses of angiotensin II binding sites and their functional significance. Mol. Pharmacol. 38: 370-377, 1990.
8. Fleming, J. T., and I. G. Joshua. Mechanism of biphasic arteriolar response to angiotensin II. Am. J. Physiol. 247 (Heart Circ. Physiol. 16): H1172-H1177, 1984.
9. Fuji, A. M., and S. F. Vatner. Direct versus indirect pressor and vasoconstrictor actions of angiotensin in conscious dogs. Hypertension 7: 253-261, 1985.
10. Hein, L., G. S. Barsh, R. E. Pratt, V. J. Dzau, and B. K. Kobilka. Behavioral and cardiovascular effects of disrupting the angiotensin II type 2 receptor gene in mice. Nature 377: 744-747, 1995.
11. Ichiki, T., P. A. Labosky, C. Sihota, S. Okuyama, Y. Imagawa, A. Fogo, F. Niimura, I. Ichikawa, B. L. M. Hogan, and T. Inagami. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377: 748-750, 1995.
12. Levy, B. I. The potential role of angiotensin II in the vasculature. J. Hum. Hypertens. 12: 283-287, 1998.
13. 2-receptor subtypes in hypertrophied rat hearts. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H844-H852, 1994.
14. 2 receptor ligands CGP42112B and PD-123319 in the sodium-depleted rat. Eur. J. Pharmacol. 249: 85-93, 1993.
15. 1 receptor-mediated pressor and chronotropic effects. J. Clin. Invest. 101: 527-535, 1998.
16. Millan, M. A., P. Carvailo, S. I. Izumi, S. Zemel, K. J. Catt, and G. Aguilera. Novel sites of expression of functional angiotensin II receptors in the late gestation fetus. Science 244: 1340-1342, 1989.
17. Munzenmaier, D. H., and A. S. Greene. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension 27: 760-765, 1996.
18. 1 receptor: gain-of-function study using gene transfer. Proc. Natl. Acad. Sci. USA 82: 10663-10667, 1995.
19. Navar, L. G., E. W. Inscho, D. S. A. Majid, J. D. Imig, L. M. Harrison-Bernard, and K. D. Mitchell. Paracrine regulation of the renal microcirculation. Physiol. Rev. 76: 425-536, 1996.
20. Nicholls, M. G., I. G. Crozier, H. Ikram, and A. M. Richards. Angiotensin II type-1 receptor antagonists in the treatment of heart failure. Int. J. Cardiol. 62, Suppl. 1: S13-S17, 1997.
21. Nio, Y., H. Matsubara, S. Murasawa, M. Kanasaki, and M. Inada. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J. Clin. Invest. 95: 46-54, 1995.
22. Ogilvie, R. I., and D. Zborowska-Sluis. Captopril and angiotensin II receptor antagonist therapy in a pacing model of heart failure. Can. J. Cardiol. 14: 1025-1033, 1998.
23. 1B receptors in blood pressure regulation. Am. J. Physiol. 272 (Renal Physiol. 41): F515-F520, 1997.
24. Peach, M. J. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol. Rev. 57: 313-370, 1977.
25. Regoli, D., W. K. Park, and N. D. Rioux. Pharmacology of angiotensin. Pharmacol. Rev. 26: 69-123, 1974.
26. Scheuer, D. A., and M. H. Perrone. Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin. Am. J. Physiol. 264 (Regulatory Integrative Comp. Physiol. 33): R917-R923, 1993.
27. Shibouta, Y. Y., M. Inada, T. Ojima, T. Wada, T. Noda, T. Sanada, K. Kubo, Y. Kohara, T. Naka, and K. Nishikawa. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole- 7-carboxylic acid (CV-11074), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl-2-ethoxy-1-{[2′-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate (TCV-116). J. Pharmacol. Exp. Ther. 266: 114-120, 1993.
28. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J. Clin. Invest. 95: 651-657, 1995.
29. Timmermans, P. B. M. W. M., P. C. Wong, A. T. Chiu, W. F. Herblin, P. Benfield, D. J. Carini, R. J. Lee, R. R. Wexler, J. M. Saye, and R. D. Smith. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 205: 205-251, 1993.
30. Tsuchida, S., T. Matsusaka, X. Chen, S. Okubo, F. Niimura, H. Nishimura, A. Fogo, H. Utsunomiya, T. Inagami, and I. Ichikawa. Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J. Clin. Invest. 101: 755-760, 1998.
31. Van Bilsen, M. Signal transduction revisited: recent developments in angiotensin II signaling in the cardiovascular system. Cardiovasc. Res. 36: 310-322, 1997.
32. Weber, M. A. Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension. J. Hypertens. 15, Suppl.: S31-S36, 1997.
33. Zhang, J., M. Pfaffendorf, and P. A. van Zwieten. Effect of various angiotensin receptor antagonists on cardiovascular responses to angiotensin II in pithed rats. J. Cardiovasc. Pharmacol. 24: 108-113, 1994.